-
Mashup Score: 1Discussing the Ever-Changing MPN Treatment Landscape - 12 month(s) ago
Andrew Kuykendall, MD, discusses recent approvals seen for patients with myeloproliferative neoplasms.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1When to Stop or Switch JAK Inhibitor Therapy in Myelofibrosis - 1 year(s) ago
CASE SUMMARYSix months ago, a 72-year-old woman with a history of hyperlipidemia (controlled on rosuvastatin [Crestor]) and hypertension (controlled on amlodipine [Norvasc]), developed itching, bloating, loss of appetite, a notable 20 lb weight loss, drenching night sweats, and significant fatigue.Abdominal examination revealed splenomegaly, spleen palpable 8 cm below the left costal margin…
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
The symptoms and care needs of patients with myeloproliferative neoplasms are discussed in a report on effective care management for these patients.
Source: Oncology Nurse AdvisorCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Roundtable Discussion: Pettit Reviews Use of JAK Inhibitors for High-risk Myelofibrosis - 1 year(s) ago
During a Targeted Oncology case-based roundtable event, Kristen M. Pettit, MD, discussed with participants the case of a patient with high-risk primary myelofibrosis and significant cytopenias.
Source: Targeted OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Overview of Myeloproliferative Neoplasms - 1 year(s) ago
A comprehensive overview of myeloproliferative neoplasms followed by insight on the differences between essential thrombocytopenia, polycythemia vera, and myelofibrosis.
Source: Targeted OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Future Directions for MPN Research - 1 year(s) ago
Srdan Verstovsek, MD, PhD, highlights what future research in myeloproliferative neoplasms looks to examine.
Source: Targeted OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2MPN Blood Cancers | Canadian MPN Research Foundation (CMPNRF) - 2 year(s) ago
We fund original Canadian research in the fight against MPN blood cancers: Primary Myelofibrosis (PM), Essential Thrombocythemia (EY) and Polycythemia Vera (PV).
Source: CMPNRFCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1MPN Blood Cancers | Canadian MPN Research Foundation (CMPNRF) - 2 year(s) ago
We fund original Canadian research in the fight against MPN blood cancers: Primary Myelofibrosis (PM), Essential Thrombocythemia (EY) and Polycythemia Vera (PV).
Source: CMPNRFCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1MPN Blood Cancers | Canadian MPN Research Foundation (CMPNRF) - 2 year(s) ago
We fund original Canadian research in the fight against MPN blood cancers: Primary Myelofibrosis (PM), Essential Thrombocythemia (EY) and Polycythemia Vera (PV).
Source: CMPNRFCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1MPN Blood Cancers | Canadian MPN Research Foundation (CMPNRF) - 2 year(s) ago
We fund original Canadian research in the fight against MPN blood cancers: Primary Myelofibrosis (PM), Essential Thrombocythemia (EY) and Polycythemia Vera (PV).
Source: CMPNRFCategories: Hem/Oncs, Latest HeadlinesTweet
RT @CanadianMpn: From @TargetedOnc: https://t.co/3g6NP2fHLQ #mpnsm #medtwitter #mpnresearch #mpnnews #mpncanada #canadianmpn